Related Experiment Video
Updated: May 21, 2026
08:30
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Von Willebrand factor deficiency and atherosclerosis
K P M van Galen1, A Tuinenburg, E M Smeets
1Department of Haematology/Van Creveldkliniek, University Medical Center Utrecht, The Netherlands. k.p.m.vangalen@umcutrecht.nl
Blood Reviews
|June 23, 2012
Summary
Von Willebrand factor (VWF) deficiency may protect against atherosclerosis, particularly through VWF-platelet interactions. Further research is needed to confirm this protective effect in humans and explore therapeutic targets.
Area of Science:
- Cardiovascular Science
- Hematology
- Pathophysiology
Background:
- Von Willebrand factor (VWF) is crucial for hemostasis and its deficiency causes von Willebrand disease (VWD).
- Elevated VWF levels correlate with increased risk of ischemic cardiovascular events.
- The role of VWF in atherogenesis remains unclear.
Purpose of the Study:
- To review evidence on whether VWF deficiency protects against atherosclerosis in humans and animals.
- To investigate the mechanisms underlying the potential protective effect of VWF deficiency.
Main Methods:
- Review of existing animal and human studies.
- Analysis of VWF's role in platelet interaction and atherogenesis.
Main Results:
- Animal studies suggest VWF deficiency or blockade protects against atherosclerosis at arterial branch points.
- The protective effect in animals is likely linked to VWF-platelet interactions.
- Human studies have not unequivocally demonstrated a protective effect of VWD on atherosclerosis, with methodological limitations.
Conclusions:
- VWF is likely involved in the interplay between the hemostatic system and atherosclerosis.
- VWF-platelet interactions represent potential targets for cardiovascular disease prevention and treatment.
- Further investigation into VWF's role in atherosclerosis is warranted.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...